Take a look at the current Grey Market Premium (GMP) for the Unihealth Consultancy IPO. The Grey Market Premium for Unihealth Consultancy IPO has recently been updated. Keep an eye out for the most up-to-date IPO GMP figures for this company.
Unihealth Consultancy, also known as UMC Hospitals, is a leading healthcare provider headquartered in Mumbai, India, with an extensive presence spanning several countries across the African continent.
Their wide range of services offered by Unihealth Consultancy includes Medical Centers, Hospitals, Consultancy Services, Distribution of Pharmaceutical and Medical Consumable Products, and Medical Value Travel.
Operating under the reputable brand name “UMC Hospitals,” they oversee a total of 200 operational hospital beds spread across two state-of-the-art multi-specialty facilities. UMC Victoria Hospital, located in Kampala, Uganda, boasts an impressive bed capacity of 120, while UMC Zhahir Hospital in Kano, Nigeria, offers 80 beds to cater to the healthcare needs of the local community. Furthermore, Unihealth operates “Unihealth Medical Centre,” a specialized dialysis facility situated in Mwanza, Tanzania, providing specialized care in the region.
Unihealth Consultancy IPO GMP
Latest IPO GMP price for Unihealth Consultancy is Rs. 18. It has an increasing trend for last 3-4 days. The IPO will be listed on 21st September 2023. Here is the GMP trend for last few days. For the latest update you can check this IPO GMP page as well.
Unihealth Consultancy IPO GMP FAQs
The current GMP for Unihealth Consultancy is Rs.18.
The expected return on the listing day would be around 13%.
It depends on your financial goal and time horizon. Also look at your risk appetite while investing in to any IPO.
The listing date for Unihealth consultancy IPO is 21st September 2023.
The Grey Market Premium (GMP) is a term commonly used in the financial world, especially in the context of Initial Public Offerings (IPOs). It refers to the difference between the unofficial market price of a newly issued IPO share and its official issue price.
In simpler terms, when a company goes public and issues shares through an IPO, there is often significant interest from investors before the shares are officially listed and traded on a stock exchange. During this interim period, investors may buy and sell these IPO shares in the secondary market, which is not regulated or authorized by stock exchanges or regulatory bodies. The price at which these shares are traded in this unofficial secondary market is referred to as the Grey Market Premium.
The Grey Market Premium can be positive or negative. A positive GMP means that the unofficial market price of the IPO share is higher than the official issue price, indicating strong demand and investor optimism about the company’s prospects. Conversely, a negative GMP suggests that the unofficial market price is lower than the issue price, which might indicate lower demand or concerns about the IPO.
Investors and market participants often monitor the Grey Market Premium as an indicator of market sentiment and demand for a particular IPO. However, it’s important to note that GMP is not an official or regulated market, and trading in the Grey Market is often speculative and carries its own set of risks.